Résistance du VIH aux antirétroviraux: Conséquences pour les pays à faibles revenus

Florence Doualla-Bell; Dan Turner; Hugues Loemba; Marco Petrella; Bluma Brenner; Mark A. Wainberg

doi:10.1051/medsci/20042010882

Résistance du VIH aux antirétroviraux: Conséquences pour les pays à faibles revenus

Translated title of the contribution: HIV drug resistance and optimization of antiviral treatment in resource-poor countries

Florence Doualla-Bell, Dan Turner, Hugues Loemba, Marco Petrella, Bluma Brenner, Mark A. Wainberg^*

^*Corresponding author for this work

Jewish General Hospital

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

HIV drug resistance has been associated with treatment failure in Western countries but the lessons learned can be useful in optimization of highly active antiretroviral treatment (HAART) in resource-poor settings. There is a need to improve access to HAART in such regions, but appropriate strategies must be rapidly implemented, such as adapted programs to facilitate adherence to therapy, rational use of genotypic drug resistance monitoring in specific situations, and use of alternative treatment regimens. The implications of HIV genetic diversity must also be considered in management of drug resistance.

Translated title of the contribution	HIV drug resistance and optimization of antiviral treatment in resource-poor countries
Original language	French
Pages (from-to)	882-886
Number of pages	5
Journal	Medecine/Sciences
Volume	20
Issue number	10
DOIs	https://doi.org/10.1051/medsci/20042010882
State	Published - Oct 2004
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1051/medsci/20042010882

Cite this

@article{39e6e2b7faf74081ac7d51cd0d6dc509,

title = "R{\'e}sistance du VIH aux antir{\'e}troviraux: Cons{\'e}quences pour les pays {\`a} faibles revenus",

abstract = "HIV drug resistance has been associated with treatment failure in Western countries but the lessons learned can be useful in optimization of highly active antiretroviral treatment (HAART) in resource-poor settings. There is a need to improve access to HAART in such regions, but appropriate strategies must be rapidly implemented, such as adapted programs to facilitate adherence to therapy, rational use of genotypic drug resistance monitoring in specific situations, and use of alternative treatment regimens. The implications of HIV genetic diversity must also be considered in management of drug resistance.",

author = "Florence Doualla-Bell and Dan Turner and Hugues Loemba and Marco Petrella and Bluma Brenner and Wainberg, {Mark A.}",

year = "2004",

month = oct,

doi = "10.1051/medsci/20042010882",

language = "צרפתית",

volume = "20",

pages = "882--886",

journal = "Medecine/Sciences",

issn = "0767-0974",

publisher = "EDP Sciences",

number = "10",

}

TY - JOUR

T1 - Résistance du VIH aux antirétroviraux

T2 - Conséquences pour les pays à faibles revenus

AU - Doualla-Bell, Florence

AU - Turner, Dan

AU - Loemba, Hugues

AU - Petrella, Marco

AU - Brenner, Bluma

AU - Wainberg, Mark A.

PY - 2004/10

Y1 - 2004/10

N2 - HIV drug resistance has been associated with treatment failure in Western countries but the lessons learned can be useful in optimization of highly active antiretroviral treatment (HAART) in resource-poor settings. There is a need to improve access to HAART in such regions, but appropriate strategies must be rapidly implemented, such as adapted programs to facilitate adherence to therapy, rational use of genotypic drug resistance monitoring in specific situations, and use of alternative treatment regimens. The implications of HIV genetic diversity must also be considered in management of drug resistance.

AB - HIV drug resistance has been associated with treatment failure in Western countries but the lessons learned can be useful in optimization of highly active antiretroviral treatment (HAART) in resource-poor settings. There is a need to improve access to HAART in such regions, but appropriate strategies must be rapidly implemented, such as adapted programs to facilitate adherence to therapy, rational use of genotypic drug resistance monitoring in specific situations, and use of alternative treatment regimens. The implications of HIV genetic diversity must also be considered in management of drug resistance.

UR - http://www.scopus.com/inward/record.url?scp=6344291439&partnerID=8YFLogxK

U2 - 10.1051/medsci/20042010882

DO - 10.1051/medsci/20042010882

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???

C2 - 15461965

AN - SCOPUS:6344291439

SN - 0767-0974

VL - 20

SP - 882

EP - 886

JO - Medecine/Sciences

JF - Medecine/Sciences

IS - 10

ER -

Résistance du VIH aux antirétroviraux: Conséquences pour les pays à faibles revenus

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this